Article
HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma.
Clinical biochemistry - 1 Apr 2010
Kruszyna Łukasz, Lianeri Margarita, Roszak Andrzej, Jagodziński Paweł P
Abstract excerpt
OBJECTIVES: It has been suggested that overexpression of HER2 in advanced cervical tumors can be considered an independent predictor of poor patient outcome. DESIGN AND METHODS: Employing PCR-RFLPs, we examined the distribution of HER2 Ile655Val (rs 1136201) genotypes and alleles in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
